Kinapse, a Syneos Health™ company, stands out as a premier provider of advisory and operational services tailored to the global life sciences sector. The company prides itself on a comprehensive service model that spans the entire clinical and commercialization lifecycle, leveraging the expertise of its founders from the biopharmaceutical sector.
Founded in 2005 and headquartered in the United Kingdom, Kinapse employs over 600 professionals across Europe, India, and the U.S.. Its distinctive "Advise – Build – Operate" model has earned the trust of numerous top 20 global biopharmaceutical firms, delivering measurable business and operational success on a worldwide scale.
The company's last financial event was an acquisition investment by Health Venture on 01 August 2018. As part of a broader industry landscape that values integrated advisory and operational prowess, Kinapse's expertise makes it a notable entity in the Biopharma, Health Care, Life Sciences, and Pharmaceutical industries.